|
Market Closed -
Nasdaq
00:00:00 29/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 432.42 USD | -1.05% |
|
-1.57% | +32.11% |
| 08-27 | UK Shares Fall as Global Tensions Mount; AstraZeneca Drops | MT |
| 08-27 | European Stocks Close Mostly Lower in Thursday Trading as Investors Await Fed Chair Speech | MT |
Company Valuation: Amgen Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 126,718 | 140,139 | 154,142 | 140,103 | 176,250 | 233,780 | - | - |
| Change | - | 10.59% | 9.99% | -9.11% | 25.8% | 32.64% | - | - |
| Enterprise Value (EV) 1 | 151,990 | 169,779 | 207,811 | 188,229 | 221,725 | 275,266 | 269,608 | 264,611 |
| Change | - | 11.7% | 22.4% | -9.42% | 17.8% | 24.15% | -2.06% | -1.85% |
| P/E | 21.9x | 21.7x | 23.1x | 34.5x | 23x | 27.4x | 24.5x | 23.6x |
| PBR | 18.7x | 38.3x | 24.7x | 23.8x | 20.4x | 20.7x | 16.9x | 13.6x |
| PEG | - | 1.2x | 7.36x | -0.9x | 0.3x | 2.5x | 2.1x | 6.37x |
| Capitalization / Revenue | 4.88x | 5.32x | 5.47x | 4.19x | 4.8x | 6x | 5.82x | 5.63x |
| EV / Revenue | 5.85x | 6.45x | 7.37x | 5.63x | 6.03x | 7.07x | 6.71x | 6.37x |
| EV / EBITDA | 9.61x | 10.5x | 11.9x | 9.13x | 10.4x | 12.6x | 12.2x | 11.9x |
| EV / EBIT | 12.2x | 13.3x | 15.5x | 12.5x | 13.7x | 16.2x | 15.3x | 14.4x |
| EV / FCF | 18.1x | 19.3x | 28.2x | 18.1x | 27.4x | 24.8x | 18.3x | 17.2x |
| FCF Yield | 5.51% | 5.17% | 3.54% | 5.52% | 3.65% | 4.04% | 5.47% | 5.82% |
| Dividend per Share 2 | 7.04 | 7.76 | 8.52 | 9 | 9.52 | 10.09 | 10.66 | 11.12 |
| Rate of return | 3.13% | 2.95% | 2.96% | 3.45% | 2.91% | 2.33% | 2.46% | 2.57% |
| EPS 2 | 10.28 | 12.11 | 12.49 | 7.56 | 14.23 | 15.81 | 17.68 | 18.33 |
| Distribution rate | 68.5% | 64.1% | 68.2% | 119% | 66.9% | 63.8% | 60.3% | 60.7% |
| Net sales 1 | 25,979 | 26,323 | 28,190 | 33,424 | 36,751 | 38,939 | 40,196 | 41,525 |
| EBITDA 1 | 15,822 | 16,178 | 17,470 | 20,620 | 21,370 | 21,919 | 22,189 | 22,265 |
| EBIT 1 | 12,424 | 12,761 | 13,399 | 15,028 | 16,203 | 16,964 | 17,660 | 18,321 |
| Net income 1 | 5,893 | 6,552 | 6,717 | 4,090 | 7,711 | 8,598 | 9,394 | 9,890 |
| Net Debt 1 | 25,272 | 29,640 | 53,669 | 48,126 | 45,475 | 41,486 | 35,828 | 30,831 |
| Reference price 2 | 224.97 | 262.64 | 288.02 | 260.64 | 327.31 | 432.42 | 432.42 | 432.42 |
| Nbr of stocks (in thousands) | 563,266 | 533,579 | 535,178 | 537,533 | 538,481 | 540,632 | - | - |
| Announcement Date | 07/02/22 | 31/01/23 | 06/02/24 | 04/02/25 | 03/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 27.35x | 7.07x | 12.56x | 2.33% | 234B | |
| 33.44x | 12.14x | 24.6x | 0.59% | 1,047B | |
| 29.82x | - | - | 2% | 646B | |
| 32.61x | 7.57x | 15.74x | 2.68% | 451B | |
| 19.99x | 4.75x | 11.76x | 2.79% | 355B | |
| 21.76x | 5.62x | 13.93x | 2.85% | 291B | |
| 20.88x | 4.29x | 12.24x | 2.06% | 252B | |
| 13.25x | 4.77x | 9.95x | 3.83% | 203B | |
| -44.51x | 6.43x | 25.11x | 2.26% | 181B | |
| 17.52x | 3.32x | 8.48x | 6.16% | 159B | |
| Average | 17.21x | 6.22x | 14.93x | 2.76% | 381.86B | |
| Weighted average by Cap. | 23.96x | 7.83x | 17.34x | 2.14% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AMGN Stock
- Valuation Amgen Inc.
Select your edition
All financial news and data tailored to specific country editions
